Defining the optimal treatment for elderly patients: lessons from real-world data.
Meier
Pascal
P
Gurm
Hitinder S
HS
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D023903:Coronary Restenosis / Q000401:mortality / Q000517:prevention & control*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007558:Italy; D008297:Male; D009203:Myocardial Infarction; D017239:Paclitaxel / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*
D000972:Antineoplastic Agents, Phytogenic; D007166:Immunosuppressive Agents; D017239:Paclitaxel; D020123:Sirolimus